placentally-derived stem cell product (Medistem)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameplacentally-derived stem cell product (Medistem)
Drug Alias NameMDS-786
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapy
Mechanisms of ActionMetastasis inhibitors
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedistem Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedistem Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A